Cargando…

Left ventricular size may predict a better CRT response

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: We know that women have better responses to cardiac resynchronization therapy (CRT) (1). A possible explanation for this greater benefit has been attributed to sex difference in left ventricular (LV) size: sex-specific differences...

Descripción completa

Detalles Bibliográficos
Autores principales:	La Greca, C, Prezioso, A, Zanchi, S, Pecora, D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	14.3 - Cardiac Resynchronisation Therapy (CRT)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207512/ http://dx.doi.org/10.1093/europace/euad122.436

Ejemplares similares

Interaction between atrial-ventricular and ventricular-ventricular delay in CRT
por: Bank, A, et al.
Publicado: (2023)

Impact of left ventricular scar burden on response to two different modalities of conduction system CRT
por: Ali, N A D I N E, et al.
Publicado: (2023)

Effects of CRT on atrial and ventricular arrhythmias in patients with HF
por: Taleski, J, et al.
Publicado: (2023)

Adaptive CRT algorithm and electrical synchrony
por: Bank, A, et al.
Publicado: (2023)

Role of RA-LV pacing in patients with symptomatic left bundle branch block with CRT - a single centre experience
por: Jhala, M, et al.
Publicado: (2023)

Both LBBP and LVSP significantly improve ventricular dyssynchrony and effectivity of LV performance compared to RV apical pacing in heart failure patients with LBBB and an indication to CRT
por: Curila, K, et al.
Publicado: (2023)

Short term outcome of different lower pacing rates in patients with recently implanted CRT
por: Ragab, A H M E D, et al.
Publicado: (2023)

Prognostic value of nutritional status in post-implant CRT outcomes in patients with chronic heart failure
por: Brochado, L, et al.
Publicado: (2023)

Effects on the timing of left ventricular pressure rise when pacing the right ventricular free wall in cardiac resynchronization therapy
por: Marciniak, M, et al.
Publicado: (2023)

Analysis of the effects of atrial pacing on the timing of left ventricular pressure rise in normal conduction and left bundle branch block
por: Marciniak, M, et al.
Publicado: (2023)

Changes in myocardial perfusion according to left ventricular pacing site in cardiac resynchronization therapy
por: Stephansen, C, et al.
Publicado: (2023)

Left ventricular global strain and duration of QRS complex as predictors of prognosis after cardiac resynchronization therapy
por: Mashal, A, et al.
Publicado: (2023)

The last shall be the first: the role of combined QLV- and CMR-determined electromechanical concordance in predicting optimal left ventricular stimulation site in cardiac resynchronisation therapy
por: Bertelli, M, et al.
Publicado: (2023)

Left bundle branch area pacing produces more physiological ventricular activation than biventricular pacing in patients with heart failure and LBBB
por: Sussenbek, O, et al.
Publicado: (2023)

Ventricular dyssynchrony assessed by ultra-high-frequency electrocardiography predicts the response to biventricular cardiac resynchronization therapy
por: Leinveber, P, et al.
Publicado: (2023)

Cardiac resynchronization therapy via left bundle branch area pacing and a dual-chamber ICD; a CROSS-LEFT substudy
por: Clementy, N, et al.
Publicado: (2023)

Left-bundle branch block, an alert for cardiac resynchronization therapy
por: Gatti, P, et al.
Publicado: (2023)

Left-to-right atrioventricular activation delay, a novel measure of AV-conduction, predicts clinical outcomes in non-LBBB patients
por: Beierle, A S, et al.
Publicado: (2023)

Stepwise application of ECG and electrogram based criteria to ensure left bundle branch pacing
por: Pujol-Lopez, M, et al.
Publicado: (2023)

Cardiac resynchronization therapy guided by activation mapping in non-left bundle branch block patients
por: Quesada Ocete, F J, et al.
Publicado: (2023)

Comparison of myocardial depolarization spreading after resynchronization with left bundle branch area pacing versus biventricular pacing
por: Zlahtic, T, et al.
Publicado: (2023)

Repolarization changes following left bundle branch area pacing versus conventional biventricular pacing in patients with dyssynchronous heart failure
por: Smits, K C, et al.
Publicado: (2023)

Predictive value of scar burden assessed by cardiac MRI on sudden cardiac death in cardiac resynchronization therapy patients: a systematic review and meta-analysis
por: Masszi, R, et al.
Publicado: (2023)

What determines who gets cardiac resynchronization therapy in europe?
por: Gatti, P, et al.
Publicado: (2023)

Correction of dyssynchrony by conduction system pacing: results of LEVEL-AT trial
por: Pujol-Lopez, M, et al.
Publicado: (2023)

The prevalence and importance of frailty in cardiac resynchronization therapy patients
por: Kuthi, L, et al.
Publicado: (2023)

Non-elective heart failure hospitalization in patients with cardiac resynchronisation therapy or dual chamber implantable cardioverter defibrillators in England: a retrospective cohort study
por: Davidson, J A, et al.
Publicado: (2023)

Long term conservation of electrical synchrony by multipoint pacing with dynamic atrioventricular delays
por: Thibault, B, et al.
Publicado: (2023)

Biventricular or conduction system pacing for cardiac resynchronization therapy: a proposed treatment algorithm based on interventricular conduction delays
por: Carmine Marallo, C M, et al.
Publicado: (2023)

Epicardial versus endocardial pacing in cardiac resynchronization therapy
por: Marciniak, M, et al.
Publicado: (2023)

The effect of Remote Monitor vs Standard of Care therapy on outcome A systematic review and meta-analysis
por: Veres, B, et al.
Publicado: (2023)

Long-term outcome in patients with heart failure and diabetes mellitus treated with cardiac resynchronization therapy
por: Jedrzejczyk-Patej, E, et al.
Publicado: (2023)

Hemodynamic optimization of cardiac resynchronization therapy by heart sound sensor in pulse generator
por: Prinzen, F, et al.
Publicado: (2023)

The risk of obesity and the association of body mass index on all-cause mortality after cardiac resynchronization therapy
por: Merkel, E D, et al.
Publicado: (2023)

Defibrillator capability and all-cause mortality in patients receiving cardiac resynchronization therapy for non-ischemic cardiomyopathy: a Korean nationwide cohort study
por: Yang, P S, et al.
Publicado: (2023)

Baseline creatinine level and long-term outcomes in patients with heart failure undergoing cardiac resynchronization therapy
por: Mazurek, M, et al.
Publicado: (2023)

Predictors of the efficacy of AV-optimised His bundle pacing in patients with a prolonged PR interval: a stratified analysis of the HOPE-HF clinical trial
por: Keene, D, et al.
Publicado: (2023)

Long-term mortality in cardiac resynchronization therapy upgrade procedures compared with de novo implantations - a nationwide cohort study
por: Bjerre, H L, et al.
Publicado: (2023)

Response to cardiac resynchronization therapy and treatment with ARNi and iSGLT2
por: Fonderico, C, et al.
Publicado: (2023)

Implantable device diagnostics on day of discharge identify heart failure patients at increased risk for early readmission for heart failure
por: Small, Roy S, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2mdo5lpt9im3kkau7rp4hrlla2